Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of azithromycin eye drops for purulent bacterial conjunctivitis in China
CTR20250228Phase 3Active
- Sponsor
- Zhejiang Shapuaisi Pharmaceutical
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin in bacterial conjunctivitis (BC), sponsored by Zhejiang Shapuaisi Pharmaceutical. Started Mar 2025; status: active.
02
Drugs
azithromycin
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on CTR20250228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250228.